Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
433.00    3.00 (0.70%)
Bid:
431.00
Ask:
433.50
Spread: 2.50 (0.58%)
Market Cap: £212.96m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

15 Dec 2022 07:00

RNS Number : 7596J
Zotefoams PLC
15 December 2022
 

Zotefoams plc

("Zotefoams" or "Group" or "Company")

 

Trading Update

Continued positive momentum through Q4 and full year profit ahead of market expectations

 

15 December 2022 - Zotefoams, a world leader in cellular materials technology, today provides an update in respect of its financial year ending 31 December 2022.

As communicated in the Group's trading update of 13 October, performance over the nine months to 30 September 2022 had been strong, with revenues approximately 24% ahead of the comparable prior year period. 

Encouragingly, trading during October and November has remained strong, with both the Polyolefin Foams and High-Performance Products businesses continuing to deliver year-on-year growth as well as a continued focus on cost and efficiency. As a result, based on current FX rates, the Board now expects Group FY22 adjusted profit before income tax to be ahead of current market expectations*, with the extent of the outperformance primarily dependent on the timing of customer shipments in the final weeks of the year.

Cash generation also continues to be positive. The better than anticipated earnings performance should contribute to an appreciable reduction in leverage compared with that reported in the interims at 30 June 2022. 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"I am pleased that Zotefoams continues to perform well and deliver excellent growth in both revenue and profitability. Whilst this year has seen considerable challenges in the form of both cost and demand volatility, we have continued to demonstrate resilience in mitigating these, which is testament to Zotefoams' well-established products and experienced team.

"Whilst we expect a number of the challenges experienced this year to continue into 2023, we are confident in our ability to respond and we continue to see significant opportunity for the Group."

 

* Current Company-compiled consensus expectations for adjusted profit before income tax and separately disclosed items, for the year ending 31 December 2022, is £10.7m.

 

 

- Ends -

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

www.zotefoams.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZMMZRDKGZZM
Date   Source Headline
7th Aug 20159:00 amRNSDirector/PDMR Shareholding
4th Aug 20157:00 amRNSHalf Yearly Report
10th Jul 20157:00 amRNSTrading Update
9th Jul 201511:38 amRNSHolding(s) in Company
2nd Jul 20157:30 amRNSDirector Declaration
23rd Jun 20154:08 pmRNSHolding(s) in Company
22nd Jun 20154:58 pmRNSHolding(s) in Company
22nd Jun 20152:39 pmRNSHolding(s) in Company
27th May 20158:57 amRNSHolding(s) in Company
13th May 20153:00 pmRNSResult of AGM
13th May 20157:00 amRNSAGM Trading Update
13th Apr 20153:22 pmRNSDirector/PDMR Shareholding
10th Apr 20159:30 amRNSAnnual Report and Notice of AGM
31st Mar 20159:26 amRNSDirector/PDMR Shareholding
30th Mar 201510:55 amRNSHolding(s) in Company
27th Mar 20153:32 pmRNSHolding(s) in Company
23rd Mar 20158:40 amRNSHolding(s) in Company
17th Mar 20157:00 amRNSFinal Results
11th Mar 20153:51 pmRNSNew venture with China-based King Lai Group
16th Jan 20154:18 pmRNSNotification of Major Interest in Shares
9th Jan 20158:47 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSTrading Update
7th Nov 20147:00 amRNSInterim Management Statement
20th Oct 20147:01 amRNSDirector Declaration
6th Oct 20142:07 pmRNSDirector/PDMR Shareholding
25th Sep 20147:00 amRNSAppointments of Non-executive Directors
19th Sep 201410:31 amRNSHolding(s) in Company
19th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 20149:45 amRNSDirector/PDMR Shareholding
17th Sep 20149:41 amRNSTotal Voting Rights
16th Sep 20144:45 pmRNSHolding(s) in Company
12th Sep 20147:00 amRNSPlacing to raise approximately £8.8m
12th Aug 20147:00 amRNSHalf Yearly Report
29th Jul 201411:17 amRNSHolding(s) in Company
30th Jun 20147:00 amRNSTrading Statement
20th May 201412:59 pmRNSResult of AGM
19th May 20147:00 amRNSAGM Statement and Interim Management Statement
13th May 20143:31 pmRNSDirectorate Change
22nd Apr 201412:41 pmRNSUnilever to use MuCell technology for Dove bottles
14th Apr 20144:04 pmRNS2013 Annual Report & Accounts and Notice of AGM
9th Apr 20149:06 amRNSDirector/PDMR Shareholding
8th Apr 20148:16 amRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNSFinal Results
15th Jan 20147:00 amRNSTrading Update
19th Nov 20134:19 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSTrading Update and Interim Management Statement
17th Oct 20131:21 pmRNSHolding(s) in Company
1st Oct 20132:13 pmRNSDirector Declaration
21st Aug 201312:15 pmRNSDirector/PDMR Shareholding
15th Aug 201312:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.